Literature DB >> 12972771

Interferon-associated combined branch retinal artery and central retinal vein obstruction.

Juan E Rubio1, Steve Charles.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972771     DOI: 10.1097/00006982-200308000-00019

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  11 in total

1.  [Acute loss of vision during therapy of chronic hepatitis C].

Authors:  J P Salgado; R Khoramnia; M M Maier; C P Lohmann; C Winkler von Mohrenfels
Journal:  Ophthalmologe       Date:  2011-06       Impact factor: 1.059

2.  Bilateral juxtapapillary choroidal neovascularisation associated with interferon alfa treatment of a metastatic cutaneous melanoma.

Authors:  J Garcia-Arumi; M Morral Palau; M Montolio Gil; H Blasco Garrido; L Sararols Ramsay; A Segura García
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 3.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

4.  Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.

Authors:  Luciana Lofego Goncalves; Alberto Queiroz Farias; Patrícia Lofego Gonçalves; Elbio-Antonio D'Amico; Flair José Carrilho
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

5.  Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.

Authors:  Iman Zandieh; Mohamed Adenwalla; Cindy Cheong-Lee; Patrick E Ma; Eric M Yoshida
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  [Combined retinal artery and vein occlusions associated with interferon beta therapy].

Authors:  T Jenisch; T Dietrich-Ntoukas; A B Renner; H Helbig; M A Gamulescu
Journal:  Ophthalmologe       Date:  2012-01       Impact factor: 1.059

Review 7.  Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.

Authors:  Ji-Hua Xue; Hai-Hong Zhu; Jing Wang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.

Authors:  Deng-Huang Su; Ying-Chun Chang; Shu-Lang Liao; Tien-Chun Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-28       Impact factor: 3.117

9.  Treatment of acute optic neuritis and vision complaints in multiple sclerosis.

Authors:  Ruben Torres-Torres; Bernardo F Sanchez-Dalmau
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.972

10.  Comorbidities in combined retinal artery and vein occlusions.

Authors:  Dieter Schmidt
Journal:  Eur J Med Res       Date:  2013-08-16       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.